More than $930,000 of Checkoff dollars will be invested to investigate Covid-29 vaccine technologies that could benefit animal health.

Checkoff dollars will also fund research to validate ASF vaccine types, efficacy and viability for commercialisation.

Finally, funding will be provided for collaborative work with the US Department of Agriculture in order to provide research and data in support of its vaccine candidate evaluation process.

These initiatives should help ensure that the industry has the tools for ASF prevention, preparation and response.